This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignees: Deutsches Krebsforschungszentrum, Ruprecht-Karis-Universität Heidelberg. Active years: 2020.
Company Filing History:
1 out of 159 
1 out of 2 Years Active: 2020
Title: Antje Wick: Innovator in Cancer Therapy
Introduction
Antje Wick is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of cancer therapy, particularly through her innovative research involving parvoviruses.
Latest Patents
Antje Wick holds a patent for a groundbreaking cancer therapy that combines a parvovirus with bevacizumab. This pharmaceutical composition is designed for the treatment of cancer, specifically targeting solid tumors. Her patent represents a novel approach to enhancing cancer treatment efficacy.
Career Highlights
Throughout her career, Antje Wick has worked with esteemed institutions such as the Deutsches Krebsforschungszentrum and Ruprecht-Karls-Universität Heidelberg. Her work has been instrumental in advancing cancer research and therapy.
Collaborations
Antje has collaborated with notable colleagues, including Karsten Geletneky and Jean Rommelaere, contributing to the collective effort in cancer research.
Conclusion
Antje Wick's innovative work in cancer therapy exemplifies the impact of scientific research on medical advancements. Her contributions continue to inspire future developments in the field.